What's breaking now, across thousands of outlets.
The FDA has made permanent the leaders of CDER and CBER, stabilizing key agency posts as a new commissioner awaits confirmation. The decision was announced by HHS on Tuesday afternoon, naming ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Sitting a lot during the day may be bad for your health but sedentary behavior with regular interruptions may lower risks of cancer mortality.
The New York Yankees may be a getting a pitcher back ahead of the MLB playoffs.
T-cell receptor, or TCR, therapy is a cancer treatment that genetically reprograms immune cells, called T cells, to hunt down cancer with precision.
The moves bring stability to an agency that's been rocked by the exits of top leadership.
Washington is phasing out direct HIV financing for Namibia after the country met UNAIDS targets, leaving over 29,000 people facing the loss of support services.
The strain of mpox behind the 2022 outbreak was a weakened form of the virus, which may have helped it spread faster, a new study from the University of Surrey reports.
